Lewes, DE -- (SBWIRE) -- 08/09/2018 -- Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Fibromyalgia in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Fibromyalgia from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered
- The United States
- EU5 (Germany, France, Italy, Spain and the United Kingdom)
- Japan

Study Period: 2016-2027

Fibromyalgia - Disease Understanding and Treatment Algorithm
Fibromyalgia (FM) is a common and complex chronic pain disorder that affects people physically, mentally and socially. It is characterized by chronic widespread pain, multiple tender points, abnormal pain processing, sleep disturbances, fatigue and often psychological distress. Fibromyalgia is mainly caused due to genetic conditions but the actual cause is still unknown. Most researchers agree that FM is a disorder of central processing with neuroendocrine/neurotransmitter dysregulation.

The Publisher Fibromyalgia market report gives the thorough understanding of the Fibromyalgia by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Fibromyalgia in the US, Europe, and Japan.

Fibromyalgia Epidemiology
The Fibromyalgia epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Publisher report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Fibromyalgia in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

According to National Fibromyalgia Association, the disorder affects an estimated 10 million people in the U.S. and an estimated 3-6% of the world population. The diagnosis is usually made between the ages of 20 to 50 years, but the incidence rises with age so that by age 80, approximately 8% of adults meet the American College of Rheumatology [ACR] classification criteria of fibromyalgia.
?
Fibromyalgia Drug Chapters
This segment of the Fibromyalgia report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Although there is no cure for Fibromyalgia, the current treatment focusses on reduction of the symptoms. Based on the drug classes, the Fibromyalgia therapeutic market is segmented as Antidepressants (Venlafaxine, Duloxetine HCl, Milnacipran HCl), Anticonvulsants (Pregabalin, Gabapentin), Muscle relaxants and Analgesics. While drug treatments are available for the symptoms of fibromyalgia, yet their efficacy varies from patient to patient, and significant side effects can limit benefits or preclude use of these medications. Thus, there is a continued need for additional effective and tolerable treatment options for patients to improve their daily functioning.

Fibromyalgia Market Outlook
The Fibromyalgia market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Key players such as Aptinyx, Astellas Pharma and Innovative med concepts are involved in developing therapies for Fibromyalgia. Expected launch of emerging therapies such as NYX-2925 (Aptinyx), ASP0819 (Astellas Pharma) and IMC-1 (Innovative med concepts) will significantly impact the Fibromyalgia market during the study period (2016-2027).

Fibromyalgia Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
?
Fibromyalgia Report Insights
- Patient Population
- Therapeutic Approaches
- Pipeline Analysis
- Market Size and Trends
- Market Opportunities
- Impact of upcoming Therapies

Fibromyalgia Report Key Strengths
- 10 Years Forecast
- 7MM Coverage
- Epidemiology Segmentation
- Sub-type Segmentation
- Key Cross Competition
- Highly Analyzed Market
- Drugs Uptake

Fibromyalgia Report Assessment
- Current Treatment Practices
- Unmet Needs
- Pipeline Product Profiles
- Market Attractiveness
- Market Drivers and Barriers

Key Benefits
- This Publisher report will help to develop Business Strategies by understanding the trends shaping and driving Fibromyalgia market
- Organize sales and marketing efforts by identifying the best opportunities for Fibromyalgia market
- To understand the future market competition in the Fibromyalgia market.

Spanning over 120 pages "Fibromyalgia - Market Insights, Epidemiology and Market Forecast-2027" report covers Report Introduction, Fibromyalgia Market Overview at a Glance, Disease Background and Overview: Fibromyalgia, Epidemiology and Patient Population, Fibromyalgia: Country- Wise Epidemiology, Treatment & Medical Practices, Marketed drugs, Emerging Therapies, Fibromyalgia: Market Size, 7MM Fibromyalgia: Country-Wise Market Analysis, Report Methodology.

Please visit this link for more details: https://www.marketresearchreports.com/delveinsight/fibromyalgia-market-insights-epidemiology-and-market-forecast-2027

Find all Drug Pipeline Reports at: https://www.marketresearchreports.com/drug-pipeline

For related reports please visit: https://www.marketresearchreports.com/search/site/Fibromyalgia

Read our Interactive Market Research Blog

About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: https://www.marketresearchreports.com/contact